Alison Helena Goodall

Title: Alison Helena Goodall: Innovator in Haemostasis

Introduction

Alison Helena Goodall is a notable inventor based in Great Britain. She has made significant contributions to the field of medical innovations, particularly in the area of haemostasis. Her work focuses on developing solutions that enhance the body's ability to stop bleeding, which is crucial in various medical situations.

Latest Patents

Alison Helena Goodall holds a patent titled "Fibrinogen Targeting Microparticles For Promoting Haemostasis." This invention provides an injectable pharmaceutical product that includes an agent with an insoluble carrier bound to a peptide. The peptide is designed to bind fibrinogen, allowing the agent to preferentially attach to activated platelets rather than inactive ones. This innovative approach aims to improve the effectiveness of treatments related to blood clotting.

Career Highlights

Alison is currently associated with Haemostatix Limited, a company dedicated to advancing medical technologies. Her role involves research and development, where she applies her expertise to create impactful medical solutions. Despite having no patents listed under her name, her contributions to the field are noteworthy.

Collaborations

Alison collaborates with Sarah Margaret Taylor, who is also involved in the medical innovation sector. Their partnership exemplifies the importance of teamwork in advancing research and development in healthcare.

Conclusion

Alison Helena Goodall is a dedicated inventor whose work in haemostasis has the potential to transform medical treatments. Her innovative approach to developing targeted therapies highlights the importance of research in improving patient outcomes.